Dissolving Microneedle Market Outlook from 2024 to 2034

The global dissolving microneedles industry is culminating to reach US$ 118.5 million by 2034 from US$ 47.2 million in 2024. Throughout this period, the market is expected to register a promising CAGR of 9.6%.

Key Highlights:

  • The lower manufacturing cost of dissolving microneedles compared to other microneedles available in the market, is augmenting their sales.
  • The increasing needle-phobic population is raising the demand for comfortable and less invasive drug delivery methods via skin. As a result, people are opting for dissolving microneedles that are tiny and cause no harm to any dermal nerve or blood vessel.
  • The surging use of dissolving microneedles to administer vaccines is becoming a popular painless vaccination technique.
  • From an ecological point of view, soluble microneedles considerably reduce the generation of hazardous medical waste. Thus, contributing to the vision of a greener planet.
Attributes Details
Dissolving Microneedle Market Size (2024) US$ 47.2 million
Dissolving Microneedle Market Forecasted Size (2034) US$ 118.5 million
Projected Value CAGR (2024 to 2034) 9.6%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Dissolving Microneedle Market Trends and Opportunities

Attributes Details
Trends
  • Increasing research and development to enhance the efficacy and expand the applications of dissolving microneedles. In addition to this, the surging use of dissolving microneedles in acne treatments, undereye patches, and as an alternative to derma rolling is projected to propel market growth. Soko Glam, Inc., for instance, has developed a product called Acropass Trouble Cure that uses a unique dissolving microneedle technology to deliver substances painlessly and efficiently.
  • Customization of the clinical treatments provided via dissolving microneedles like the depth of these needles and the presence of active chemicals to effectively treat the skin condition is influencing the market growth.
Opportunities
  • In this digital space, there are breakthrough opportunities for manufacturers of dissolving microneedles. A related futuristic use of dissolving microneedles is in digital medicine. By developing convergence systems that offer information on drug loading amounts, controlled release rates, and patch change intervals, advanced usage of dissolving microneedles can change the face of drug administration.
  • In future, the use of dissolvable microneedles in the pharmaceutical sector is expected to be more openly explored. Companies are striving for better treatment for health conditions like osteoporosis, Alzheimer's disease, and others, which often require a once-daily injection. Thus, the introduction of these less invasive needles in the pharma sector is expected to give hope for a better quality of life.

Dissolving Microneedle Industry Analysis by Region

The scope of dissolving microneedles is lucrative in Europe, owing to inflating discretionary income and a high degree of willingness for cosmetic treatments. Two important places where demand and sales of dissolving microneedles are predicted to be high are Germany and the United Kingdom. Meanwhile, North America is expected to register a comparatively lower demand for dissolving microneedles.

Consumption of this instrument is predicted to expand on account of the rising concentration of manufacturers, amplified marketing, and increasing desire to undergo minimally invasive aesthetic procedures, and continuous advancements.

The promising growth of dissolving microneedle business in the Asia Pacific is predicted to propel investors and stakeholders to increase their stake in this region. The significant influence of the West is predicted to be a key catalyst for the sales of dissolving microneedles for aesthetic purposes. Additionally, increasing the use of these needles for the transdermal delivery of several drugs is predicted to advance the regional market.

Country Forecasted CAGR (2024 to 2034)
The United States 9.6%
Germany 14.1%
The United Kingdom 12.8%
China 10.7%
Japan 10.2%

The United States is Witnessing Rising Use of Dissolving Microneedles to Deliver Drugs

The United States dissolving microneedle market is expected to lead in North America by a substantial market share. As per the latest estimates by FMI analysts, the market in the United States is projected to register a promising 9.6% CAGR through 2034. Following factors back this growth:

  • Surge in consumer spending on cosmetic treatments like acne treatment and wrinkle treatment.
  • Increasingly occurring skin diseases in the country.
  • Advancing technology of dissolving microneedles allowing it to be used to administer various medications directly into the skin. In 2020, for instance, microneedles were used to deliver viral proteins into the skin to induce an immune response by the University of Connecticut, Vaxess, and Verndari.
  • Rising investments in research and development activities to increase the applications of dissolving microneedles.
  • Growing concentration of leading manufacturers in the United States.

Dissolving Microneedle Manufacturers Find More Openness for These Instruments in Germany

Germany is a notable market for dissolving microneedles in Europe. The country is estimated by FMI analysts to record an impressive CAGR of 14.1% through 2034. Key factors that are driving this growth are:

  • Increasing use of dissolving microneedles to efficiently enhance dermal drug delivery.
  • Significant progress made by dissolving microneedles in the field of vaccine delivery, disease diagnosis, and monitoring.
  • This instrument exhibits significant potential in clinical treatment. Therefore, manufacturers in the country are investing and increasing their capacity to make full use of this latent opportunity.
  • Some common factors that are propelling market growth include the expanding geriatric population, rising patient awareness, and increasing healthcare infrastructure.

Versatility of Dissolving Microneedles in Raising its Application in the United Kingdom

Consumption of dissolving microneedles in the United Kingdom is predicted to shoot up at a CAGR of 12.8% through 2034. Given below are some of the salient growth factors:

  • Surging use of dissolving microneedles for the transdermal delivery of several drugs as they are emerging as a versatile drug delivery system.
  • Key players in the country are undertaking strategic initiatives like agreements, partnerships, collaboration, and others.
  • Increasing market for dissolving microneedles as patients of infectious and chronic diseases is rising at a consistent rate.

Growing Preference for Modern Therapeutic Methods in China is Cultivating a Market for Dissolving Microneedle

The dissolving microneedle market in China is expected to surge at a compounded rate of 10.7% through 2034. The adoption of dissolving microneedles is driven by:

  • Accelerating use of dissolving microneedles to deliver drugs into the patient’s body.
  • Frequent use of dissolving microneedles in aesthetic procedures like hair development and skin care.
  • Emerging demand for cutting-edge therapeutic and medical methods among consumers in China is increasing investments in dissolving microneedles.

Commercialization of Advanced Dissolving Microneedles in Japan Elevating the Market Scope

In Japan, the consumption of dissolving microneedles is projected to increase at a CAGR of 10.2%. The market is supported by following factors:

  • Increasing commercialization of dissolving microneedles in Japan is enhancing the market scope in the country.
  • Surging rate of skin disorders in the country.
  • Rising demand for cutting-edge dermal acne patches.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Dissolving Microneedle Industry Analysis by Segment

Dissolving Microneedles are Becoming a Popular Choice in the Wrinkle Treatment

Attributes Details
Top Application Wrinkle Treatment
Market Share in 2024 85.3%

As per the latest dissolving microneedle market research report, the wrinkle treatment is estimated to acquire a massive value share of 85.3% in 2024. Key factors that are propelling market growth are as follows:

  • Growing interest of population in treatments that promise youthful and glowing skin, as well as prevention of signs of aging is increasing this segment’s growth. Booming anti-aging market is increasing the application of dissolving microneedles for its minimal invasion and effective treatment.
  • High efficacy of dissolving microneedle is increasing its use in wrinkle treatment. These needles once injected into the skin, trigger the production of elastin and collagen and give the skin its elasticity and plumpness. Thus, reducing the appearance of wrinkles and fine lines.

Online Stores are the Preferred Distribution Channel for Buying Dissolving Microneedle

Attributes Details
Top Distribution Channel Online Stores
Market Share in 2024 41.0%

Online stores segment is projected to procure a market share of 41.0% in 2024. Top factors that are predicted to expand the market growth are as follows:

  • Increasing smartphone ownership and rising internet penetration are contributing to heightened sales of dissolving microneedles via online platforms owing to easy accessibility and convenience.
  • Growing segment of consumers who prefer discreetness and privacy are hopping onto the online channel, especially for concerns like facial rejuvenation and wrinkle reduction. These platforms offer a convenient environment to undergo such treatments without public exposure.
  • Consumers prefer online stores due to the greater transparency provided by them, thus fostering trust and encouraging customers to make purchases from online mediums.

Top Growth Strategies for the Dissolving Microneedle Market Players in 2024 and Beyond

Several strategies have been devised to help businesses and manufacturers bump up their position in the dissolving microneedle industry. Some of these strategies have been outlined below:

  • Diversification of dissolving microneedle offerings beyond primary applications like wrinkle treatment into fields like pain management, vaccine delivery, and chronic disease monitoring.
  • Improvement of microneedle designs to enhance drug delivery, elevate user comfort, and target certain skin layers.
  • Increase investment in the research of biocompatible and biodegradable materials with improved functionality and safety.
  • Capturing new markets in emerging economies that have significant growth potential.
  • Strengthening distribution channel of dissolving microneedle by offering them via direct-to-consumer models, online platforms, and partnerships with beauty retailers and pharmacies.

Recent Developments in the Dissolving Microneedle Market

  • In 2024, CD Formulation, a contract pharmaceutical formulation development services, declared that it is introducing dissolving microneedle preparation services. This competitive innovation in drug delivery technology offers to revolutionize the healthcare sector and enhance the efficiency and patient comfort.
  • Raphas Co., Ltd., in February 2022, reportedly formed a research partnership with Johnson & Johnson to bring progress in skin health solutions. The partnership is aimed at exclusively developing and applying microneedle particles, made of Raphas’ patented Droplet Extension (DEN) technology in skin care products.
  • Vice Reversa, which is a next-Gen precision skincare firm, announced in October 2021 that it is investing to expand the company’s geographical presence.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Dissolving Microneedle Manufacturers

  • CosMED Pharmaceutical Co.Ltd.
  • Micron Biomedical, Inc.
  • Raphas Co., Ltd
  • Nissha Co., Ltd
  • Micropoint Technologies
  • Small Lab
  • Vice Reversa
  • NINGBO CHIMED TECHNOLOGY CO., LTD
  • Vaxess Technologies, Inc.
  • QuadMedicine
  • Others

Key Segments in the Dissolving Microneedle Market Report

By Application:

  • Wrinkle Treatment
  • Acne Treatment

By Distribution Channel:

  • Retail Stores
  • Supermarkets and Hypermarkets
  • Online Stores
  • Aesthetic/Cosmetic Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

How Big is the Dissolving Microneedle Market?

The dissolving microneedle industry is estimated to be valued at US$ 47.2 million in 2024.

What is the Future Forecast of the Dissolving Microneedle Market?

The dissolving microneedle market size is forecast to surpass US$ 118.5 million by 2034.

What is the Projected CAGR for the Dissolving Microneedle Industry?

The CAGR of the dissolving microneedle industry is projected to be around 9.6% through 2034.

Which are the Leading Companies offering Dissolving Microneedle?

CosMED Pharmaceutical Co.Ltd., Micron Biomedical, Inc., and Raphas Co., Ltd are dissolving microneedle industry leaders.

Which Region is Projected to Significantly Appreciate the Market’s Growth?

Europe is expected to make a significant contribution to the overall market growth.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Producers
            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
            3.5.1.3. Wholesalers and Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Wholesalers and Distributors
        3.7.3. Retailers
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
    4.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis, 2019 to 2023
    4.2. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Projections, 2024 to 2034
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Application, 2019 to 2023
    5.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Application, 2024 to 2034
        5.3.1. Wrinkle Treatment
        5.3.2. Acne Treatment
    5.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023
    5.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Distribution Channel, 2019 to 2023
    6.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Distribution Channel, 2024 to 2034
        6.3.1. Retail Stores
        6.3.2. Supermarkets & Hypermarkets
        6.3.3. Online Stores
        6.3.4. Aesthetic/Cosmetic Clinics
    6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023
    6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    7.1. Introduction
    7.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Region, 2019 to 2023
    7.3. Current Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Region, 2024 to 2034
        7.3.1. North America
        7.3.2. Latin America
        7.3.3. Western Europe
        7.3.4. Eastern Europe
        7.3.5. South Asia and Pacific
        7.3.6. East Asia
        7.3.7. Middle East and Africa
    7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    8.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
    8.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
        8.2.1. By Country
            8.2.1.1. USA
            8.2.1.2. Canada
        8.2.2. By Application
        8.2.3. By Distribution Channel
    8.3. Market Attractiveness Analysis
        8.3.1. By Country
        8.3.2. By Application
        8.3.3. By Distribution Channel
    8.4. Key Takeaways
9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    9.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
    9.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
        9.2.1. By Country
            9.2.1.1. Brazil
            9.2.1.2. Mexico
            9.2.1.3. Rest of Latin America
        9.2.2. By Application
        9.2.3. By Distribution Channel
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Application
        9.3.3. By Distribution Channel
    9.4. Key Takeaways
10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    10.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
    10.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
        10.2.1. By Country
            10.2.1.1. Germany
            10.2.1.2. UK
            10.2.1.3. France
            10.2.1.4. Spain
            10.2.1.5. Italy
            10.2.1.6. Rest of Western Europe
        10.2.2. By Application
        10.2.3. By Distribution Channel
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Application
        10.3.3. By Distribution Channel
    10.4. Key Takeaways
11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    11.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
    11.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
        11.2.1. By Country
            11.2.1.1. Poland
            11.2.1.2. Russia
            11.2.1.3. Czech Republic
            11.2.1.4. Romania
            11.2.1.5. Rest of Eastern Europe
        11.2.2. By Application
        11.2.3. By Distribution Channel
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Application
        11.3.3. By Distribution Channel
    11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    12.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
    12.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
        12.2.1. By Country
            12.2.1.1. India
            12.2.1.2. Bangladesh
            12.2.1.3. Australia
            12.2.1.4. New Zealand
            12.2.1.5. Rest of South Asia and Pacific
        12.2.2. By Application
        12.2.3. By Distribution Channel
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Application
        12.3.3. By Distribution Channel
    12.4. Key Takeaways
13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    13.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
    13.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
        13.2.1. By Country
            13.2.1.1. China
            13.2.1.2. Japan
            13.2.1.3. South Korea
        13.2.2. By Application
        13.2.3. By Distribution Channel
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Application
        13.3.3. By Distribution Channel
    13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    14.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
    14.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
        14.2.1. By Country
            14.2.1.1. GCC Countries
            14.2.1.2. South Africa
            14.2.1.3. Israel
            14.2.1.4. Rest of MEA
        14.2.2. By Application
        14.2.3. By Distribution Channel
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Application
        14.3.3. By Distribution Channel
    14.4. Key Takeaways
15. Key Countries Market Analysis
    15.1. USA
        15.1.1. Pricing Analysis
        15.1.2. Market Share Analysis, 2023
            15.1.2.1. By Application
            15.1.2.2. By Distribution Channel
    15.2. Canada
        15.2.1. Pricing Analysis
        15.2.2. Market Share Analysis, 2023
            15.2.2.1. By Application
            15.2.2.2. By Distribution Channel
    15.3. Brazil
        15.3.1. Pricing Analysis
        15.3.2. Market Share Analysis, 2023
            15.3.2.1. By Application
            15.3.2.2. By Distribution Channel
    15.4. Mexico
        15.4.1. Pricing Analysis
        15.4.2. Market Share Analysis, 2023
            15.4.2.1. By Application
            15.4.2.2. By Distribution Channel
    15.5. Germany
        15.5.1. Pricing Analysis
        15.5.2. Market Share Analysis, 2023
            15.5.2.1. By Application
            15.5.2.2. By Distribution Channel
    15.6. UK
        15.6.1. Pricing Analysis
        15.6.2. Market Share Analysis, 2023
            15.6.2.1. By Application
            15.6.2.2. By Distribution Channel
    15.7. France
        15.7.1. Pricing Analysis
        15.7.2. Market Share Analysis, 2023
            15.7.2.1. By Application
            15.7.2.2. By Distribution Channel
    15.8. Spain
        15.8.1. Pricing Analysis
        15.8.2. Market Share Analysis, 2023
            15.8.2.1. By Application
            15.8.2.2. By Distribution Channel
    15.9. Italy
        15.9.1. Pricing Analysis
        15.9.2. Market Share Analysis, 2023
            15.9.2.1. By Application
            15.9.2.2. By Distribution Channel
    15.10. Poland
        15.10.1. Pricing Analysis
        15.10.2. Market Share Analysis, 2023
            15.10.2.1. By Application
            15.10.2.2. By Distribution Channel
    15.11. Russia
        15.11.1. Pricing Analysis
        15.11.2. Market Share Analysis, 2023
            15.11.2.1. By Application
            15.11.2.2. By Distribution Channel
    15.12. Czech Republic
        15.12.1. Pricing Analysis
        15.12.2. Market Share Analysis, 2023
            15.12.2.1. By Application
            15.12.2.2. By Distribution Channel
    15.13. Romania
        15.13.1. Pricing Analysis
        15.13.2. Market Share Analysis, 2023
            15.13.2.1. By Application
            15.13.2.2. By Distribution Channel
    15.14. India
        15.14.1. Pricing Analysis
        15.14.2. Market Share Analysis, 2023
            15.14.2.1. By Application
            15.14.2.2. By Distribution Channel
    15.15. Bangladesh
        15.15.1. Pricing Analysis
        15.15.2. Market Share Analysis, 2023
            15.15.2.1. By Application
            15.15.2.2. By Distribution Channel
    15.16. Australia
        15.16.1. Pricing Analysis
        15.16.2. Market Share Analysis, 2023
            15.16.2.1. By Application
            15.16.2.2. By Distribution Channel
    15.17. New Zealand
        15.17.1. Pricing Analysis
        15.17.2. Market Share Analysis, 2023
            15.17.2.1. By Application
            15.17.2.2. By Distribution Channel
    15.18. China
        15.18.1. Pricing Analysis
        15.18.2. Market Share Analysis, 2023
            15.18.2.1. By Application
            15.18.2.2. By Distribution Channel
    15.19. Japan
        15.19.1. Pricing Analysis
        15.19.2. Market Share Analysis, 2023
            15.19.2.1. By Application
            15.19.2.2. By Distribution Channel
    15.20. South Korea
        15.20.1. Pricing Analysis
        15.20.2. Market Share Analysis, 2023
            15.20.2.1. By Application
            15.20.2.2. By Distribution Channel
    15.21. GCC Countries
        15.21.1. Pricing Analysis
        15.21.2. Market Share Analysis, 2023
            15.21.2.1. By Application
            15.21.2.2. By Distribution Channel
    15.22. South Africa
        15.22.1. Pricing Analysis
        15.22.2. Market Share Analysis, 2023
            15.22.2.1. By Application
            15.22.2.2. By Distribution Channel
    15.23. Israel
        15.23.1. Pricing Analysis
        15.23.2. Market Share Analysis, 2023
            15.23.2.1. By Application
            15.23.2.2. By Distribution Channel
16. Market Structure Analysis
    16.1. Competition Dashboard
    16.2. Competition Benchmarking
    16.3. Market Share Analysis of Top Players
        16.3.1. By Regional
        16.3.2. By Application
        16.3.3. By Distribution Channel
17. Competition Analysis
    17.1. Competition Deep Dive
        17.1.1. CosMED Pharmaceutical Co.Ltd.
            17.1.1.1. Overview
            17.1.1.2. Product Portfolio
            17.1.1.3. Profitability by Market Segments
            17.1.1.4. Sales Footprint
            17.1.1.5. Strategy Overview
                17.1.1.5.1. Marketing Strategy
                17.1.1.5.2. Product Strategy
                17.1.1.5.3. Channel Strategy
        17.1.2. Micron Biomedical, Inc.
            17.1.2.1. Overview
            17.1.2.2. Product Portfolio
            17.1.2.3. Profitability by Market Segments
            17.1.2.4. Sales Footprint
            17.1.2.5. Strategy Overview
                17.1.2.5.1. Marketing Strategy
                17.1.2.5.2. Product Strategy
                17.1.2.5.3. Channel Strategy
        17.1.3. Raphas Co., Ltd
            17.1.3.1. Overview
            17.1.3.2. Product Portfolio
            17.1.3.3. Profitability by Market Segments
            17.1.3.4. Sales Footprint
            17.1.3.5. Strategy Overview
                17.1.3.5.1. Marketing Strategy
                17.1.3.5.2. Product Strategy
                17.1.3.5.3. Channel Strategy
        17.1.4. Nissha Co., Ltd
            17.1.4.1. Overview
            17.1.4.2. Product Portfolio
            17.1.4.3. Profitability by Market Segments
            17.1.4.4. Sales Footprint
            17.1.4.5. Strategy Overview
                17.1.4.5.1. Marketing Strategy
                17.1.4.5.2. Product Strategy
                17.1.4.5.3. Channel Strategy
        17.1.5. Micropoint Technologies
            17.1.5.1. Overview
            17.1.5.2. Product Portfolio
            17.1.5.3. Profitability by Market Segments
            17.1.5.4. Sales Footprint
            17.1.5.5. Strategy Overview
                17.1.5.5.1. Marketing Strategy
                17.1.5.5.2. Product Strategy
                17.1.5.5.3. Channel Strategy
        17.1.6. Vice Reversa
            17.1.6.1. Overview
            17.1.6.2. Product Portfolio
            17.1.6.3. Profitability by Market Segments
            17.1.6.4. Sales Footprint
            17.1.6.5. Strategy Overview
                17.1.6.5.1. Marketing Strategy
                17.1.6.5.2. Product Strategy
                17.1.6.5.3. Channel Strategy
        17.1.7. NINGBO CHIMED TECHNOLOGY CO., LTD
            17.1.7.1. Overview
            17.1.7.2. Product Portfolio
            17.1.7.3. Profitability by Market Segments
            17.1.7.4. Sales Footprint
            17.1.7.5. Strategy Overview
                17.1.7.5.1. Marketing Strategy
                17.1.7.5.2. Product Strategy
                17.1.7.5.3. Channel Strategy
        17.1.8. Vaxess Technologies, Inc.
            17.1.8.1. Overview
            17.1.8.2. Product Portfolio
            17.1.8.3. Profitability by Market Segments
            17.1.8.4. Sales Footprint
            17.1.8.5. Strategy Overview
                17.1.8.5.1. Marketing Strategy
                17.1.8.5.2. Product Strategy
                17.1.8.5.3. Channel Strategy
        17.1.9. QuadMedicine
            17.1.9.1. Overview
            17.1.9.2. Product Portfolio
            17.1.9.3. Profitability by Market Segments
            17.1.9.4. Sales Footprint
            17.1.9.5. Strategy Overview
                17.1.9.5.1. Marketing Strategy
                17.1.9.5.2. Product Strategy
                17.1.9.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Recommendations

Healthcare

Needle-Free Vaccine Injectors Market

September 2024

REP-GB-13704

250 pages

Healthcare

Microneedle Drug Delivery Systems Market

June 2024

REP-GB-2750

345 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Dissolving Microneedle Market

Schedule a Call